Illumina’s directors were given additional insurance to close the Grail deal
Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A Grogan | CNBC Carl Icahn claimed on Friday that Illumina’s directors were demanding additional personal liability insurance before the biotech company signed a $7.1 billion acquisition of cancer test developer Grail in 2021. The claim is the latest development in … Read more